# NeurAxis, Inc. (NRXS)

> Source: Nexqual · https://nexqual.com/NRXS · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, NeurAxis, Inc. (NRXS), nexqual.com/NRXS" · informational, not investment advice.

**Price:** USD 7.74 (+18.53% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 6.53 · day 6.8–7.81 · 52w 2.21–9.33 · market cap $97.2M · ASE

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (2 analysts), mean target USD 11 (range 9–13).
- Total return with dividends: 1Y +146.5% vs S&P 500 +18.1%; 5Y +25.9% vs S&P 500 +85.1%.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 2 analysts; mean target USD 11 (low 9, high 13).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2023-08-07) |
|---|---|---|
| Total return | +146.5% | +25.9% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +147.3% | +7.5% |
| Volatility (annualized) | 75.9% | 79.0% |
| Max drawdown | -39.5% (Oct 2025→Nov 2025) | -74.0% (Aug 2023→Apr 2025) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/NRXS · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt